CFO4Life Group’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.35M | Sell |
16,283
-797
| -5% | -$121K | 0.36% | 49 |
|
|
2025
Q4 | $2.45M | Sell |
17,080
-688
| -4% | -$101K | 0.35% | 49 |
|
|
2025
Q3 | $2.73M | Buy |
17,768
+130
| +0.7% | +$20.3K | 0.4% | 47 |
|
|
2025
Q2 | $2.81M | Sell |
17,638
-682
| -4% | -$111K | 0.44% | 43 |
|
|
2025
Q1 | $3.12M | Sell |
18,320
-339
| -2% | -$56.8K | 0.53% | 40 |
|
|
2024
Q4 | $3.13M | Buy |
18,659
+122
| +0.7% | +$20.8K | 0.55% | 34 |
|
|
2024
Q3 | $3.21M | Buy |
18,537
+24
| +0.1% | +$4.07K | 0.57% | 32 |
|
|
2024
Q2 | $3.05M | Buy |
18,513
+295
| +2% | +$48.2K | 0.57% | 32 |
|
|
2024
Q1 | $2.96M | Sell |
18,218
-405
| -2% | -$63.5K | 0.54% | 33 |
|
|
2023
Q4 | $2.73M | Sell |
18,623
-471
| -2% | -$69.8K | 0.52% | 35 |
|
|
2023
Q3 | $2.79M | Sell |
19,094
-406
| -2% | -$62K | 0.64% | 30 |
|
|
2023
Q2 | $2.96M | Sell |
19,500
-55
| -0.3% | -$8.29K | 0.63% | 29 |
|
|
2023
Q1 | $2.91M | Sell |
19,555
-233
| -1% | -$33.3K | 0.66% | 27 |
|
|
2022
Q4 | $3M | Buy |
19,788
+78
| +0.4% | +$10.9K | 0.64% | 31 |
|
|
2022
Q3 | $2.49M | Sell |
19,710
-352
| -2% | -$50K | 0.66% | 27 |
|
|
2022
Q2 | $2.88M | Sell |
20,062
-614
| -3% | -$92.3K | 0.71% | 26 |
|
|
2022
Q1 | $3.16M | Sell |
20,676
-983
| -5% | -$154K | 0.66% | 27 |
|
|
2021
Q4 | $3.54M | Buy |
21,659
+91
| +0.4% | +$13.5K | 0.73% | 24 |
|
|
2021
Q3 | $3.02M | Buy |
21,568
+791
| +4% | +$112K | 0.7% | 27 |
|
|
2021
Q2 | $2.8M | Buy |
20,777
+20
| +0.1% | +$2.71K | 0.65% | 27 |
|
|
2021
Q1 | $2.81M | Sell |
20,757
-453
| -2% | -$59.1K | 0.7% | 25 |
|
|
2020
Q4 | $2.95M | Buy |
21,210
+484
| +2% | +$67.6K | 0.85% | 24 |
|
|
2020
Q3 | $2.88M | Sell |
20,726
-300
| -1% | -$39.8K | 0.98% | 22 |
|
|
2020
Q2 | $2.51M | Sell |
21,026
-801
| -4% | -$93.4K | 0.97% | 21 |
|
|
2020
Q1 | $2.4M | Sell |
21,827
-88
| -0.4% | -$10.6K | 1.28% | 16 |
|
|
2019
Q4 | $2.74M | Sell |
21,915
-56
| -0.3% | -$6.85K | 1.16% | 20 |
|
|
2019
Q3 | $2.73M | Sell |
21,971
-101
| -0.5% | -$11.9K | 1.23% | 19 |
|
|
2019
Q2 | $2.42M | Sell |
22,072
-618
| -3% | -$65.9K | 1.11% | 21 |
|
|
2019
Q1 | $2.36M | Sell |
22,690
-665
| -3% | -$64.7K | 1.11% | 20 |
|
|
2018
Q4 | $2.15M | Sell |
23,355
-796
| -3% | -$71.2K | 0.94% | 26 |
|
|
2018
Q3 | $2.01M | Sell |
24,151
-5,007
| -17% | -$409K | 0.89% | 28 |
|
|
2018
Q2 | $2.28M | Buy |
29,158
+25,554
| +709% | +$1.92M | 0.95% | 25 |
|
|
2018
Q1 | $286K | Sell |
3,604
-370
| -9% | -$30.8K | 0.24% | 70 |
|
|
2017
Q4 | $365K | Buy |
3,974
+294
| +8% | +$26.4K | 0.29% | 59 |
|
|
2017
Q3 | $335K | Sell |
3,680
-219
| -6% | -$19.9K | 0.27% | 71 |
|
|
2017
Q2 | $340K | Buy |
3,899
+229
| +6% | +$20.2K | 0.31% | 64 |
|
|
2017
Q1 | $330K | Buy |
+3,670
| New | +$325K | 0.3% | 63 |
|
Other funds holding PG
VCM
VPM
CFO4Life Group's PG Position: Q1 2026 in Review
CFO4Life Group reduced its Procter & Gamble (PG) stake by 4.7% in Q1 2026, selling an estimated $121K and leaving 16,283 shares worth $2.35M. The position accounts for 0.36% of the portfolio, ranked #49.
CFO4Life Group first reported a position in PG in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.54M in Q4 2021. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.
- CFO4Life Group held 16,283 shares of Procter & Gamble worth $2.35M as of Q1 2026.
- CFO4Life Group sold 797 Procter & Gamble shares in Q1 2026, an estimated $121K.
- Procter & Gamble made up 0.36% of CFO4Life Group's portfolio in Q1 2026, its #49 holding.
- CFO4Life Group first reported a position in Procter & Gamble in Q1 2017 and has held it in 37 quarters since.
- CFO4Life Group's Procter & Gamble position peaked at $3.54M in Q4 2021.
- 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.
Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.